The Innovative Medicines Initiative has now launched IMI2 – Call 17.
These topics address academics, SMEs, mid-sized enterprises, patient groups, regulators, and others working in areas as diverse as medical research, drug development, public health and more.
Call 17 is a standard two-stage call for proposals with the following topics:
Deadline for short proposals: 25 April 2019
You can find the call web page here.
All topic texts, call documentation and details of how to apply can be found on the IMI website.
+++ information on webinars +++
IMI is currently running webinars on IMI2 – Call 17, including webinars on all call topics, as well as IMI’s rules and procedures and opportunities for small and medium-sized enterprises (SMEs). Tips on finding partners and preparing your proposal.
Why apply? - IMI calls for proposals represent an excellent opportunity for researchers to take part in ground-breaking collaborative projects that aim to deliver tangible benefits for patients. Scientists from academia, industry, SMEs, mid-sized companies, hospitals and patients’ organisations are encouraged to get involved in projects.
Questions? E-mail firstname.lastname@example.org
You can find more information on these webinars here.